Insider Transactions in Q3 2025 at Liquidia Corp (LQDA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2025
|
Raman Singh Director |
SELL
Open market or private sale
|
Direct |
7,500
-19.35%
|
$217,500
$29.42 P/Share
|
|
Sep 02
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
1,148
-0.32%
|
$33,292
$29.05 P/Share
|
|
Sep 02
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
1,063
-0.18%
|
$30,827
$29.05 P/Share
|
|
Sep 02
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
70,692
-10.81%
|
$1,979,376
$28.76 P/Share
|
|
Sep 02
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
328,268
-24.08%
|
$9,191,504
$28.91 P/Share
|
|
Sep 02
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
451
-0.26%
|
$13,079
$29.05 P/Share
|
|
Aug 29
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
296
-0.16%
|
$8,584
$29.05 P/Share
|
|
Aug 29
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.65%
|
-
|
|
Aug 29
2025
|
Sarah Krepp Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
209
-0.15%
|
$6,061
$29.05 P/Share
|
|
Aug 29
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.4%
|
-
|
|
Aug 29
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.82%
|
-
|
|
Aug 29
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
188,232
-19.87%
|
$5,082,264
$27.62 P/Share
|
|
Aug 29
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+0.89%
|
-
|
|
Aug 28
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
154,337
-14.01%
|
$4,167,099
$27.94 P/Share
|
|
Aug 28
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.41%
|
$540,000
$27.85 P/Share
|
|
Aug 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
26,057
-13.22%
|
$703,539
$27.86 P/Share
|
|
Aug 19
2025
|
Joanna Horobin Director |
SELL
Open market or private sale
|
Direct |
5,000
-12.9%
|
$135,000
$27.17 P/Share
|
|
Aug 15
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
20,000
-5.31%
|
$520,000
$26.18 P/Share
|
|
Aug 05
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
30,000
-7.38%
|
$600,000
$20.0 P/Share
|
|
Jul 28
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,063
-0.57%
|
$20,197
$19.54 P/Share
|
|
Jul 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
454
-0.23%
|
$8,626
$19.54 P/Share
|
|
Jul 21
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,526
-0.93%
|
$35,364
$14.54 P/Share
|
|
Jul 14
2025
|
Sarah Krepp Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
2,673
-1.84%
|
$37,422
$14.28 P/Share
|
|
Jul 14
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,797
-2.1%
|
$67,158
$14.28 P/Share
|
|
Jul 14
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,327
-1.92%
|
$74,578
$14.28 P/Share
|
|
Jul 14
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
7,836
-1.34%
|
$109,704
$14.28 P/Share
|
|
Jul 14
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,576
-1.31%
|
$36,064
$14.28 P/Share
|
|
Jul 14
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,193
-0.63%
|
$16,702
$14.28 P/Share
|
|
Jul 14
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,504
-1.91%
|
$567,056
$14.28 P/Share
|
|
Jul 14
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
11,580
-2.77%
|
$162,120
$14.28 P/Share
|
|
Jul 11
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,381
+1.59%
|
-
|
|
Jul 11
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,107
+1.34%
|
-
|
|
Jul 11
2025
|
Rajeev Saggar Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,531
+1.26%
|
-
|
|
Jul 11
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,759
+0.64%
|
-
|
|
Jul 11
2025
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,666
+1.29%
|
-
|
|
Jul 11
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,828
+1.38%
|
-
|
|
Jul 01
2025
|
Dana Boyle Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.72%
|
-
|
|
Jul 01
2025
|
Sarah Krepp Chief Human Resource Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+14.69%
|
-
|